Log in

Don't have an account? Register here

Forgotten password?

Dupilumab: first biologic treatment for atopic eczema

The National Eczema Society is delighted that the National Institute for Health and Care Excellence (NICE) has now approved the biologic drug Dupilumab for routine use on the NHS in England and Wales, and that the Scottish Medicines Consortium (SMC) has accepted Dupilumab for use by NHS Scotland.

 

The first new drug treatment for atopic eczema in many years, Dupilumab offers real hope to people living with more severe eczema. 

For further information about Dupilumab, please have a look at our Dupilumab factsheet.

Dupilumab: first biologic treatment for atopic ...

Related documents